top of page
Modern Cityscape at Night

Biotech beyond borders.

Connecting APAC capital with global innovation in health & life sciences.

Kellbridge Capital Partners executes venture-side advisory & capital partnerships, and investor-side deal origination.

Our Focus

BioTech

Therapeutics, diagnostics, and platform technologies that harness biology to transform patient outcomes and global health. Our focus spans novel drug modalities, synthetic biology, and research technologies.

MedTech

Medical devices, diagnostics, and digital tools that improve the precision, efficiency, and accessibility of care. We work with ventures developing next-generation hardware, imaging, sensors, and other clinical innovations.

HealthTech

Intelligent devices, AI platforms, wearables, and digital tools in healthcare. We work with innovations that enhance clinical development, health management, improve monitoring, and deliver proactive care directly to consumers.

What We Do

Private Capital Advisory for Ventures

We work with high-potential life sciences ventures to develop their capital strategy, investment narratives, and execute targeted investor engagement with aligned APAC investors. Our focus is on delivering partnerships that deliver both capital and strategic value for regional growth.

Mandate-led Deal Origination for Investors

We provide deal origination for APAC investors, leveraging our global network of investors, ecosystem partners, and strategic experts to deliver high-quality global life sciences opportunities against a specified mandate.

Fund & Platform Capital Advisory

We support fund managers, venture platforms, and investment vehicles on capital strategy, positioning, and targeted engagement with strategic and institutional LPs across APAC and global markets.

Who we work with

For more information,
please use the form provided

Thank you for your message

Contact

© Kellbridge Capital Partners. All rights reserved.

bottom of page